INNOVATION1 BIOTECH INC. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/253af8f9-8cab-4972-98f9-6770343770e0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-6.0M | 2022-09-01 – 2023-08-31 | evidence 0001477932-24-000223 |
| FY 2022 | $-40.9M | 2021-09-01 – 2022-08-31 | evidence 0001477932-22-009309 |
| FY 2021 | $1.0M | 2020-09-01 – 2021-08-31 | evidence 0001477932-21-009127 |
| FY 2020 | $-2.6M | 2019-09-01 – 2020-08-31 | evidence 0001477932-20-007273 |
| FY 2019 | $-170.1k | 2018-09-01 – 2019-08-31 | evidence 0001477932-19-007157 |
| FY 2018 | $-975.5k | 2017-09-01 – 2018-08-31 | evidence 0001477932-18-005998 |
| FY 2017 | $-35.9k | 2016-09-01 – 2017-08-31 | evidence 0001477932-17-006105 |
| FY 2016 | $-35.0k | 2015-09-01 – 2016-08-31 | evidence 0001477932-16-013939 |
| FY 2015 | $-14.5k | 2014-09-01 – 2015-08-31 | evidence 0001477932-16-013939 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
INNOVATION1 BIOTECH INC. — all facts · Revenue · Operating Income